What is BCB Bancorp's trial loan modifications?

BCB Bancorp (BCBP) reported trial loan modifications of $46.75M in Q4 2025.

How has BCB Bancorp's trial loan modifications changed year-over-year?

BCB Bancorp's trial loan modifications decreased by 41.4% year-over-year, from $79.8M to $46.75M.

Over 4 years (2020 to 2025), BCB Bancorp's trial loan modifications has grown at a 30.6% compound annual growth rate (CAGR), from $16.06M to $46.75M.

Revenue$24.9M+4.8%

Net income$4.9M+159%

EPS (diluted)$0.26+151%

Cash & equivalents$293.7M+16.2%

Total debt$236.4M-43.3%

Total equity$307.4M-2.3%

Total assets$3.3B-5.9%

Operating cash flow$5.2M+3.3%

CapEx$266.0K-8.6%

Free cash flow$4.9M+4.0%

Market cap$178.49M+26.9%

Enterprise value$121.12M—

P/E254.6×—

P/S1.7×—

Net margin0.7%-4.1pp

FCF margin34.1%-33.3pp

Return on equity0.2%-1.2pp

Debt / equity0.8×-0.6×

Reported directly by BCB Bancorp in its filing.

Tagged under the XBRL concept us-gaap:FinancingReceivableModificationsRecordedInvestment.

The official record: BCB Bancorp’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is BCB Bancorp's trial loan modifications?: BCB Bancorp (BCBP) reported trial loan modifications of $46.75M in Q4 2025.
How has BCB Bancorp's trial loan modifications changed year-over-year?: BCB Bancorp's trial loan modifications decreased by 41.4% year-over-year, from $79.8M to $46.75M.
What is the long-term trend for BCB Bancorp's trial loan modifications?: Over 4 years (2020 to 2025), BCB Bancorp's trial loan modifications has grown at a 30.6% compound annual growth rate (CAGR), from $16.06M to $46.75M.